<DOC>
	<DOCNO>NCT02863588</DOCNO>
	<brief_summary>Ocular toxoplasmosis ( OT ) major cause visual impairment worldwide . OT responsible 30 50 % posterior uveitis . It characterize dormant infection may reactivate without known reason , cause severe irreversible visual loss . The overall recurrence rate OT Europe great 80 % patient may range one episode 11 episode ( 1 % OT ) extreme case . Current treatment reduce risk recurrence risk toxoplasmosis recurrence predict immunocompetent patient . These clinical biological expression change might relate individual genetic susceptibility patient . The advanced analysis entire genome possible consider project .</brief_summary>
	<brief_title>Determination Genetic Susceptibility Severe Recurrences Ocular Toxoplasmosis</brief_title>
	<detailed_description />
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Disease Susceptibility</mesh_term>
	<mesh_term>Genetic Predisposition Disease</mesh_term>
	<mesh_term>Toxoplasmosis</mesh_term>
	<mesh_term>Toxoplasmosis , Ocular</mesh_term>
	<criteria>seropositive Toxoplasma gondii ( patient parent ) Infection genotype II ( patient parent ) ocular toxoplasmosis recurrence &gt; 5 ( patient ) Parents seronegative T. gondii infection Infection others genotypes type II</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>